Unfortunately, Cytodyn is not going to fix the corrupt mess of the FDA system or even correct the narrowmindness of it. Cytodyn must navigate the system as it is. Doing trials and studies with leronlimab as a combo with som BP drug likely is the path. Leronlimab does not need it, but that is the vehicle to carry leronlimab through this. We should have jumped on those opportunities long ago.